Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,986 | 5,153 | 12,683 | 19,866 | 17,785 |
| TOTAL | $20,110 | $5,610 | $13,846 | $20,530 | $18,761 |
| Non-Current Assets | |||||
| PPE Net | 894 | 337 | 376 | 419 | 339 |
| Other Non-Current Assets | 547 | 562 | 616 | 642 | 219 |
| TOTAL | $1,441 | $900 | $992 | $1,060 | $558 |
| Total Assets | $21,551 | $6,509 | $14,839 | $21,590 | $19,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,815 | 6,392 | 6,905 | 5,478 | 6,367 |
| Other current liabilities | 8,600 | N/A | N/A | 5,972 | N/A |
| TOTAL | $16,471 | $6,445 | $6,956 | $11,502 | $6,515 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,433 | 531 | 548 | 1,935 | 54 |
| TOTAL | $18,433 | $531 | $548 | $1,935 | $54 |
| Total Liabilities | $34,904 | $6,976 | $7,504 | $13,437 | $6,569 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 409 | 324 | 324 | 324 | 313 |
| Retained earnings | -210,034 | -196,302 | -188,080 | -159,990 | -172,284 |
| TOTAL | $-13,353 | $-467 | $7,335 | $8,153 | $12,751 |
| Total Liabilities And Equity | $21,551 | $6,509 | $14,839 | $21,590 | $19,320 |